Kindstar Globalgene Technology, Inc. (9960.HK) — Stock Score Summary

Kindstar Globalgene Technology, Inc. (9960.HK) has a MoatMap StockRank of 61/100 based on Quality (45/100), Value (68/100), and Momentum (33/100) factor scores. The current signal is HOLD. Kindstar Globalgene is a specialized clinical laboratory service provider in China with low liquidity and a lack of clear near-term macro catalysts.

Kindstar Globalgene Technology, Inc. is a leading independent clinical laboratory (ICL) in China, specializing in high-end esoteric testing services such as hematology, oncology, and genetics. The company provides advanced diagnostic services to thousands of hospitals, leveraging its extensive testing menu and advanced molecular biology platforms. Its competitive moat is defined by high technical entry barriers, strong physician relationships, and a dominant share in the domestic hematology testing market.

Key Financial Metrics

Price$0.13
Market Cap$139M
P/E (Forward)8.58
Price/Book0.32
Return on Equity-2.0%
Return on Invested Capital-0.8%
Debt/Equity14.86
Gross Margin44.1%
Operating Margin-21.6%
Revenue Growth4.9%
Dividend Yield9.3%
Free Cash Flow$1M

Kindstar Globalgene Technology, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Kindstar Globalgene Technology, Inc.’s (9960.HK) StockRank?
MoatMap’s StockRank for Kindstar Globalgene Technology, Inc. (9960.HK) is 61/100, with a Hold signal. It is a composite of Quality (45), Value (68), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Kindstar Globalgene Technology, Inc. have an economic moat?
Kindstar Globalgene Technology, Inc. (9960.HK) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Kindstar Globalgene Technology, Inc. a buy, hold, or sell?
MoatMap’s current signal for Kindstar Globalgene Technology, Inc. (9960.HK) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Kindstar Globalgene Technology, Inc. in?
Kindstar Globalgene Technology, Inc. (9960.HK) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).
Browse all ranked stocks9960.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock